期刊
CLINICA CHIMICA ACTA
卷 426, 期 -, 页码 6-11出版社
ELSEVIER
DOI: 10.1016/j.cca.2013.08.012
关键词
25-Hydroxyvitamin D; Interlaboratory comparison; Quality assurance; Immunoassay; Liquid chromatography; Mass spectrometry
资金
- NIH-ODS
Background: The National Institute of Standards and Technology (NIST), in collaboration with the National Institutes of Health Office of Dietary Supplements, established the first accuracy-based program for improving the comparability of vitamin D metabolite measurements, the Vitamin D Metabolites Quality Assurance Program. Methods: The study samples were human serum or plasma Standard Reference Materials (SRMs) with 25-hydroxyvitamin D values that were determined at NIST. Participants evaluated the materials using immunoassay (IA), liquid chromatography (LC) with mass spectrometric detection, and LC with ultraviolet absorbance detection. NISI' evaluated the results for concordance within the participant community as well as trueness relative to the NIST value. Results: For the study materials that contain mostly 25-hydroxyvitamin D-3 (25(OH)D3),the coefficient of variation (CV) for the participant results was consistently in the range from 7% to 19%, and the median values were biased high relative to the NIST values. However, for materials that contain significant concentrations of both 25-hydroxyvitamin 1)2 (25(OH)D-2) and 25(OH)D-3, the median IA results were biased lower than both the LC and the NIST values, and the CV was as high as 28%. The first interlaboratory comparison results for SRM 972a Vitamin D Metabolites in Human Serum are also reported. Conclusions: Relatively large within-lab and between-lab variability hinders conclusive assessments of bias and accuracy. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据